‘Ensuring data protection is crucial for clinical activity’
Incorporated in India in 1994, Roche Scientific Company (India), is a wholly owned subsidiary of the Basel (Switzerland)-based F Hoffmann LA Roche (FHLR). In 1993, FHLR entered into an agreement with Nicholas Piramal India to market and manufacture some of its products, but this was terminated in 2003. Roche is now going on its own, and launching Avastin, its cancer drug, here, just a few months after its global launch. Dr G Telang, the company’s Managing Director, spoke to MG Arun on the new patent scenario and Roche’s future plans in India.